Blood–nanomaterials interactions

Tatiana Avsievich, Ruixue Zhu, Alexey Popov, Alexander Bykov, Igor Meglinski

Research output: Chapter in Book/Report/Conference proceedingChapter or book articleScientificpeer-review

Abstract

Due to an overwhelming amount of nanoparticles (NPs) used in modern industry and medicine, human exposure to NPs is inevitable, raising safety concerns of their application. Blood–NP interactions appear after NP internalization into the human body regardless of the uptake route. The interaction mode of NPs with blood depends on NPs’ intrinsic properties and is largely affected by the physiological environment, making it hard to relate observed effects with these factors. In the present chapter NP interactions and the following outcomes were revised separately for the main blood components: plasma proteins, leukocytes, platelets, and red blood cells. Possible toxic effects along with approaches to avoid them were also described for each blood component.
Original languageEnglish
Title of host publicationNanotechnology for Hematology, Blood Transfusion, and Artificial Blood
PublisherElsevier
Chapter1
Pages1-40
ISBN (Print)978-0-12-823971-1
DOIs
Publication statusPublished - 2021
MoE publication typeA3 Part of a book or another research book

Keywords

  • Blood
  • Hemocompatibility
  • Leukocytes
  • Nanoparticles
  • Plasma proteins
  • Platelets
  • Red blood cells
  • Toxicity

Fingerprint

Dive into the research topics of 'Blood–nanomaterials interactions'. Together they form a unique fingerprint.

Cite this